Steve Jobs
Diagnosed in 2003 with a rare, slow-growing pancreatic neuroendocrine tumour, he put off surgery for about nine months while trying diet and alternative approaches. His case is the standard example in discussions of delay and unproven therapies.
Steve Jobs (1955-2011) was diagnosed in October 2003 with a pancreatic neuroendocrine tumour, a rarer and generally slower-growing disease than pancreatic adenocarcinoma and often curable by surgery when caught early. According to his authorised biographer, Walter Isaacson, he resisted an operation for around nine months, pursuing diet-based and alternative treatments, before undergoing a Whipple procedure in July 2004; Isaacson reported that Jobs later regretted the delay. He had a liver transplant in 2009 for metastatic disease, and had his tumour and germline genomes sequenced, an early instance of personal cancer genomics. He died on 5 October 2011 at 56. Clinicians cannot know whether earlier surgery would have changed his outcome, and his case is cited here not as a verdict but as the reason the conversation about delay, evidence and patient autonomy is had so often.
Pages like this
not linked directly; found by shared links- PersonRandy Pausch
Shares Patients lack understanding, navigation and agency and the tags hero, patient.
- PersonStephen Sutton
Shares Patients lack understanding, navigation and agency and the tags hero, patient.
- PersonAshya King
Shares Patients lack understanding, navigation and agency and the tags hero, patient.
- PersonHenrietta Lacks
Shares Patients lack understanding, navigation and agency and the tags hero, patient.
- PersonAlexandra "Alex" Scott
Shares the tags hero, patient.
- PersonBarbara Bradfield
Shares the tags hero, patient.
- PersonBud Romine
Shares the tags hero, patient.
- PersonChadwick Boseman
Shares the tags hero, patient.